Cytokinetics | CYTK - Interest Expense On Debt



Cytokinetics reported $24.26M in Interest Expense on Debt for its fiscal quarter ending in June of 2025.


Interest Expense On Debt Change Date
Acadia Pharmaceuticals 0 4.12M Sep/2024
Amgen USD 694M 29M Jun/2025
Bayer 495M 89M Jun/2025
Biogen USD 72.6M 12.6M Jun/2025
Bristol-Myers Squibb USD 485M 9M Jun/2025
Cytokinetics USD 24.26M 1.32M Jun/2025
Eisai 916M 174M Jun/2025
Eli Lilly USD 249M 5.3M Jun/2025
Exelixis 23.4M 3.9M Sep/2023
Geron USD 8.52M 233K Jun/2025
Halozyme Therapeutics USD 4.39M 131K Jun/2025
Ionis Pharmaceuticals USD 19M 0 Jun/2025
Ligand Pharmaceuticals USD 1.15M 286K Jun/2025
Merck USD 305M 8M Jun/2025
Novartis USD 289M 19M Jun/2025
Pfizer USD 654M 0 Jun/2025
Regeneron Pharmaceuticals USD 3.6M 5.1M Jun/2025
Roche Holding CHF 311.5M 1000K Dec/2024
Sanofi 148M 65M Jun/2025